Guillain–Barré syndrome following coronavirus disease vaccine: First report from Nepal

Guillain–Barré syndrome following coronavirus disease vaccine: First report from Nepal

ChAdOx1 nCoV-19 is an effective and well-tolerated coronavirus disease 2019 vaccine. However, rare cases of serious adverse events have been reported with it. We report a patient who did not have active or prior coronavirus disease 2019 infection, who developed Guillain–Barré syndrome 7 days followi...

Full description

Bibliographic Details
Main Authors: Prajjwol Luitel, Bibek Poudel, Devansh Upadhyay, Sujan Paudel, Nishan Tiwari, Bikram Prasad Gajurel, Ragesh Karn, Reema Rajbhandari, Aashish Shrestha, Niraj Gautam, Rajeev Ojha
Format: Article
Language:English
Published: SAGE Publishing 2022-05-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X221100876

Internet

https://doi.org/10.1177/2050313X221100876

Similar Items